Report error Found 3 Enz. Inhib. hit(s) with all data for entry = 13487
TargetProto-oncogene tyrosine-protein kinase receptor Ret [658-1114](Human)
Shanghai Daidai Investment Consulting Co.
US Patent
Shanghai Daidai Investment Consulting Co.
US Patent
Affinity DataIC50: 5.60nMAssay Description:The ability of compounds to antagonize human A2A and A2B adenosine receptors was determined using a kit to measure changes in intracellular cyclic AM...More data for this Ligand-Target Pair
TargetProto-oncogene tyrosine-protein kinase receptor Ret [658-1114](Human)
Shanghai Daidai Investment Consulting Co.
US Patent
Shanghai Daidai Investment Consulting Co.
US Patent
Affinity DataIC50: 23.1nMAssay Description:The ability of compounds to antagonize human A2A and A2B adenosine receptors was determined using a kit to measure changes in intracellular cyclic AM...More data for this Ligand-Target Pair
TargetProto-oncogene tyrosine-protein kinase receptor Ret [658-1114](Human)
Shanghai Daidai Investment Consulting Co.
US Patent
Shanghai Daidai Investment Consulting Co.
US Patent
Affinity DataIC50: 25.4nMAssay Description:The ability of compounds to antagonize human A2A and A2B adenosine receptors was determined using a kit to measure changes in intracellular cyclic AM...More data for this Ligand-Target Pair
